The Asia Pacific Immunization Coalition (APIC) and the Asia Dengue Voice & Action (ADVA), with the Centre for Behavi...
South Korea-based SK bioscience, and global healthcare leader Sanofi, are strengthening their partnership to jointly tar...
Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (H...
Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...
Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...
In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...
South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...
Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...
A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...
The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...
Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...
Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...
